日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

更正:达莫克托格α聚乙二醇(Damoctocog Alfa Pegol),一种聚乙二醇化B结构域缺失的重组长效凝血因子VIII,用于治疗A型血友病:产品评测

Reding, Mark T; Lalezari, Shadan; Kenet, Gili; Di Minno, Giovanni; Ducore, Jonathan; Solms, Alexander; Shah, Anita; Holme, Pål André; Poulsen, Lone H; Meijer, Karina; Simpson, Mindy; Mancuso, Maria Elisa

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII

在 PROTECT VIII 研究中,达莫克托格α聚乙二醇预防治疗对年龄在 12 至 18 岁之间的 A 型血友病患者具有长期疗效和安全性

Reding, Mark T; Simpson, Mindy; Ducore, Jonathan; Holme, Pål Andrè; Maas Enriquez, Monika; Mancuso, Maria Elisa

Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk

医学影像与儿童和青少年血液肿瘤风险

Smith-Bindman, Rebecca; Alber, Susan A; Kwan, Marilyn L; Pequeno, Priscila; Bolch, Wesley E; Bowles, Erin J A; Greenlee, Robert T; Stout, Natasha K; Weinmann, Sheila; Moy, Lisa M; Stewart, Carly; Francisco, Melanie; Kofler, Cameron; Duncan, James R; Ducore, Jonathan; Mahendra, Malini; Pole, Jason D; Miglioretti, Diana L

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Damoctocog Alfa Pegol,一种聚乙二醇化B结构域缺失的重组长效凝血因子VIII,用于治疗A型血友病:产品评测

Reding, Mark T; Lalezari, Shadan; Kenet, Gili; Di Minno, Giovanni; Ducore, Jonathan; Solms, Alexander; Shah, Anita; Holme, Pål André; Poulsen, Lone H; Meijer, Karina; Simpson, Mindy; Mancuso, Maria Elisa

Medical imaging utilization and associated radiation exposure in children with down syndrome

唐氏综合征儿童的医学影像检查利用及相关辐射暴露

Marlow, Emily C; Ducore, Jonathan M; Kwan, Marilyn L; Bowles, Erin J A; Greenlee, Robert T; Pole, Jason D; Rahm, Alanna K; Stout, Natasha K; Weinmann, Sheila; Smith-Bindman, Rebecca; Miglioretti, Diana L

Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors

Eptacog beta 在治疗和控制伴有抑制剂的 A 型或 B 型血友病患儿(<12 岁)出血方面的疗效和安全性

Pipe, Steven W; Hermans, Cédric; Chitlur, Meera; Carcao, Manuel; Castaman, Giancarlo; Davis, Joanna A; Ducore, Jonathan; Dunn, Amy L; Escobar, Miguel; Journeycake, Janna; Khan, Osman; Mahlangu, Johnny; Meeks, Shannon L; Mitha, Ismail Haroon; Négrier, Claude; Nowak-Göttl, Ulrike; Recht, Michael; Chrisentery-Singleton, Tammuella; Stasyshyn, Oleksandra; Vilchevska, Kateryna V; Martinez, Laura Villarreal; Wang, Michael; Windyga, Jerzy; Young, Guy; Alexander, W Allan; Bonzo, Daniel; Macie, Christopher; Mitchell, Ian S; Sauty, Evelyne; Wilkinson, Thomas A; Shapiro, Amy D

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study

Simoctocog Alfa (Nuwiq) 用于既往未接受治疗的重型血友病 A 患者:NuProtect 研究的最终结果

Liesner, Ri J; Abraham, Aby; Altisent, Carmen; Belletrutti, Mark J; Carcao, Manuel; Carvalho, Manuela; Chambost, Hervé; Chan, Anthony K C; Dubey, Leonid; Ducore, Jonathan; Gattens, Michael; Gresele, Paolo; Gruel, Yves; Guillet, Benoit; Jimenez-Yuste, Victor; Kitanovski, Lidija; Klukowska, Anna; Lohade, Sunil; Mancuso, Maria Elisa; Oldenburg, Johannes; Pavlova, Anna; Pollio, Berardino; Sigaud, Marianne; Vdovin, Vladimir; Vilchevska, Kateryna; Wu, John K M; Jansen, Martina; Belyanskaya, Larisa; Walter, Olaf; Knaub, Sigurd; Neufeld, Ellis J

Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome

一项针对390万名患有和未患有唐氏综合征的儿童的队列研究分析了白血病风险

Marlow, Emily C; Ducore, Jonathan; Kwan, Marilyn L; Cheng, Stephanie Y; Bowles, Erin J A; Greenlee, Robert T; Pole, Jason D; Rahm, Alanna Kulchak; Stout, Natasha K; Weinmann, Sheila; Smith-Bindman, Rebecca; Miglioretti, Diana L

PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors

PERSEPT 3:一项 3 期临床试验,旨在评估 eptacog beta(重组人 FVIIa)在伴有抑制剂的 A 型或 B 型血友病患者围手术期治疗中的止血疗效。

Escobar, Miguel; Luck, James; Averianov, Yevhenii; Ducore, Jonathan; Fernández, Maria Fernanda López; Giermasz, Adam; Hart, Daniel P; Journeycake, Janna; Kessler, Craig; Leissinger, Cindy; Mahlangu, Johnny; Martinez, Laura Villarreal; Miesbach, Wolfgang; Mitha, Ismail Haroon; Quon, Doris; Reding, Mark T; Schved, Jean-François; Stasyshyn, Oleksandra; Vilchevska, Kateryna V; Wang, Michael; Windyga, Jerzy; Alexander, W Allan; Al-Sabbagh, Ahmad; Bonzo, Daniel; Mitchell, Ian S; Wilkinson, Thomas A; Hermans, Cédric

The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors

活化型依普塔克β在成人和儿童血友病伴抑制剂患者出血事件管理和围手术期止血中的安全性

Escobar, Miguel; Castaman, Giancarlo; Boix, Santiago Bonanad; Callaghan, Michael; de Moerloose, Philippe; Ducore, Jonathan; Hermans, Cédric; Journeycake, Janna; Leissinger, Cindy; Luck, James; Mahlangu, Johnny; Miesbach, Wolfgang; Mitha, Ismail Haroon; Négrier, Claude; Quon, Doris; Recht, Michael; Schved, Jean François; Shapiro, Amy D; Sidonio, Robert Jr; Srivastava, Alok; Stasyshyn, Oleksandra; Vilchevska, Kateryna V; Wang, Michael; Young, Guy; Alexander, W Allan; Al-Sabbagh, Ahmad; Bonzo, Daniel; Macie, Christopher; Wilkinson, Thomas A; Kessler, Craig